BTK inhibitor combined with anti-PD-1 monoclonal antibody for the treatment of CD20-negative primary central nervous system lymphoma: A case report

CD20-negative diffuse large B-cell lymphoma (DLBCL) is a rare type of lymphoproliferative disorder characterized by a high degree of aggressiveness, a tendency for extranodal invasion and chemotherapeutic resistance. CD20-negative DLBCL originating from the nervous system is rarer. In primary centra...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Lan, Gao, Xiaohui, Jiao, Zhiyun, Wang, Zheng, Min, Fenglin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811622/
https://www.ncbi.nlm.nih.gov/pubmed/36644138
http://dx.doi.org/10.3892/ol.2022.13634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811622/
https://www.ncbi.nlm.nih.gov/pubmed/36644138
http://dx.doi.org/10.3892/ol.2022.13634

Ejemplares similares